Peripheral Neuropathy in Patients With Colorectal Cancer Receiving Oxaliplatin

被引:56
|
作者
Tofthagen, Cindy [1 ]
McAllister, R. Denise [1 ]
McMillan, Susan C. [1 ]
机构
[1] Univ S Florida, Coll Nursing, Tampa, FL 33620 USA
关键词
III COLON-CANCER; ADJUVANT CHEMOTHERAPY; UNPLEASANT SYMPTOMS; PAIN; NEUROTOXICITY; GUIDELINES; MANAGEMENT; SLEEP;
D O I
10.1188/11.CJON.182-188
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neuropathic side effects are commonly reported in patients receiving oxaliplatin, but little is known about the characteristics of peripheral neuropathy in this patient population. The purpose of this descriptive study was to explore the prevalence of neuropathic symptoms in patients with colorectal cancer receiving oxaliplatin as well as to explore symptom severity, distress, frequency, and neuropathic interference with activities. Thirty-three patients receiving oxaliplatin at two outpatient facilities completed the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool. Data were analyzed using descriptive statistics. Cold sensitivity, tingling in the hands, and numbness in the hands were the most prevalent neuropathic symptoms, and cold sensitivity, nerve pain, and trouble with balance were the most severe symptoms. Trouble with balance, muscle or joint aches, and neuropathic pain were the most distressing symptoms, and numbness in the fingers and hands and in the toes and feet were the most frequent symptoms. Patients reported that neuropathic symptoms interfered with numerous activities. Oncology nurses can use this information to help educate patients and families about potential side effects of oxaliplatin and to coordinate the care of patients with peripheral neuropathy using a symptom-focused, multidisciplinary approach.
引用
下载
收藏
页码:182 / 188
页数:7
相关论文
共 50 条
  • [41] Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients
    Wang, Wei-Shu
    Lin, Jen-Kou
    Lin, Tzu-Chen
    Chen, Wei-Shone
    Jiang, Jeng-Kae
    Wang, Huann-Sheng
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Yen, Chueh-Chuan
    Chen, Po-Min
    ONCOLOGIST, 2007, 12 (03): : 312 - 319
  • [42] Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer
    Kono, Toru
    Mamiya, Noriaki
    Chisato, Naoyuki
    Ebisawa, Yosiaki
    Yamazaki, Hirotaka
    Watari, Jiro
    Yamamoto, Yasuhiro
    Suzuki, Shigetaka
    Asama, Toshiyuki
    Kamiya, Kazunori
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 2011 : 1 - 8
  • [43] PERIPHERAL NEUROPATHY IN PATIENTS RECEIVING TAXOTERE CHEMOTHERAPY
    BALMACEDA, C
    FORSYTH, P
    SEIDMAN, AD
    FRANCIS, P
    DEANGELIS, LM
    ANNALS OF NEUROLOGY, 1993, 34 (02) : 313 - 313
  • [44] Efficacy of glutamine added to calcium/magnesium on oxaliplatin-induced peripheral sensory neuropathy in patients with colorectal cancer, a phase III study
    Samson, B.
    Dube, P.
    Aucoin, N.
    Wierzbicki, R.
    Maroun, J.
    Letourneau, R.
    Chen, E.
    Charpentier, D.
    Grassin, H.
    Kavan, P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S518 - S519
  • [45] Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV
    Bruno Vincenzi
    Anna Maria Frezza
    Gaia Schiavon
    Chiara Spoto
    Raffaele Addeo
    Vincenzo Catalano
    Francesco Graziano
    Daniele Santini
    Giuseppe Tonini
    Supportive Care in Cancer, 2013, 21 : 1313 - 1319
  • [46] Incidence of oxaliplatin-induced peripheral sensory neuropathy in patients with colorectal cancer treated by FOLFOX regimen at a regional community hospital in Quebec
    Luiz, Guimaraes Jose
    Raynald, Simard
    Sabina, Rusu
    Nancy, Aylwin
    ANNALS OF ONCOLOGY, 2017, 28
  • [47] Incidence, characteristics, and associations of oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: Results of a prospective, multicenter, international study.
    Argyriou, Andreas
    Alberti, Paola
    Briani, Chiara
    Velasco, Roser
    Bruna, Jordi
    Campagnolo, Marta
    Cazzaniga, Marina Elena
    Bergamo, Francesca
    Cortinovis, Diego Luigi
    Santos, Cristina
    Papadimitriou, Konstantinos
    Cavaletti, Guido
    Kalofonos, Haralabos
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV
    Vincenzi, Bruno
    Frezza, Anna Maria
    Schiavon, Gaia
    Spoto, Chiara
    Addeo, Raffaele
    Catalano, Vincenzo
    Graziano, Francesco
    Santini, Daniele
    Tonini, Giuseppe
    SUPPORTIVE CARE IN CANCER, 2013, 21 (05) : 1313 - 1319
  • [49] Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale
    Karen Kaiser
    Madison Lyleroehr
    Sara Shaunfield
    Leilani Lacson
    Maria Corona
    Sheetal Kircher
    Malin Nittve
    David Cella
    World Journal of Gastrointestinal Oncology, 2020, 12 (02) : 205 - 218
  • [50] Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale
    Kaiser, Karen
    Lyleroehr, Madison
    Shaunfield, Sara
    Lacson, Leilani
    Corona, Maria
    Kircher, Sheetal
    Nittve, Malin
    Cella, David
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (02) : 205 - 218